HSP90AA1, another candidate biomarker for identification, has previously been shown (He et al., 2023) to be strongly associated with the increase of infiltrating T cells in PAH and serves as a potential analytical target for the identification of PAH. Here, HSP90AA1 is linked to pulmonary arterial hypertension.